News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Doshi Dipal
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $15.6713, valued at
$15.7k
|
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $12, valued at
$24k
|
|
| 01/30/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $12.0005, valued at
$24k
|
|
| 01/10/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,410 shares
@ $15.0189, valued at
$36.2k
|
|
| 12/29/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 600 shares
@ $14.7989, valued at
$8.9k
Sold 9,069 shares
@ $15.0384, valued at
$136.4k
Sold 4,521 shares
@ $15.0081, valued at
$67.9k
Sold 400 shares
@ $15.0128, valued at
$6k
|
|
| 11/30/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $13.9131, valued at
$27.8k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 3,402 shares
@ $15.1162, valued at
$51.4k
Sold 1,023 shares
@ $15.066, valued at
$15.4k
|
|
| 09/19/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 200 shares
@ $15.04, valued at
$3k
|
|
| 09/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 30,250 shares
@ $0
Granted 181,500 options to buy
@ $11.57, valued at
$2.1M
|
|
| 01/18/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $1.74, valued at
$17.4k
|
|
| 11/01/2021 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 184,821 options to buy
@ $20, valued at
$3.7M
|
|
|
|